The copper influx transporter human copper transport protein 1 regulates the uptake of cisplatin in human ovarian carcinoma cells

Molecular Pharmacology

Volumn 66, Issue 4, 2004, Pages 817-823

  Holzer, Alison K ^b   Samimi, Goli ^b   Katano, Kuniyuki ^b   Naerdemann, Wiltrud ^b   Lin, Xinjian ^b   Safaei, Roohangiz ^b   Howell, Stephen B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CISPLATIN; COMPLEMENTARY DNA; COPPER; COPPER CARRIER PROTEIN 1; PLATINUM; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DNA DRUG COMPLEX; DRUG UPTAKE; GROWTH RATE; HOMEOSTASIS; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; BIOLOGICAL TRANSPORT; CATION TRANSPORT PROTEINS; CISPLATIN; COPPER; FEMALE; GENE EXPRESSION; HUMANS; OVARIAN NEOPLASMS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 4844228226     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.001198     Document Type: Article

References (27)

1. Amtmann E, Zoller M, Wesch H, and Schilling G (2001) Antitumoral activity of a sulphur-containing platinum complex with an acidic pH optimum. Cancer Chemother Pharmacol 47:461-466.
2. Andrews PA and Albright KD (1991) Role of membrane ion transport in cisplatin accumulation, in Platinum and Other Metal Coordination Compounds in Cancer Chemotherapy (Howell SB ed) pp 151-159, Plenum Press, New York.
3. Andrews PA and Howell SB (1990) Cellular pharmacology of cisplatin: perspectives on mechanisms of acquired resistance. Cancer Cells 2:35-43.
4. Andrews PA, Schiefer MA, Murphy MP, and Howell SB (1988) Enhanced potentiation of cisplatin cytotoxicity in human ovarian carcinoma cells by prolonged glutathione depletion. Chem Biol Interact 65:51-58.
5. Atema A, Buurman KJ, Noteboom E, and Smets LA (1993) Potentiation of DNA-adduct formation and cytotoxicity of platinum- containing drugs by low pH. Int J Cancer 54:166-172.
6. Deutscher MP ed (1990) Preparation of Extracts from Higher Eukaryotes. Academic Press, San Diego.
7. Eisses JF and Kaplan JH (2002) Molecular characterization of hCTR1, the human copper uptake protein. J Biol Chem 277:29162-29171.
8. Endo T, Kimura O, and Sakata M (2000) Carrier-mediated uptake of cisplatin by the OK renal epithelial cell line. Toxicology 146:187-195.
9. Gately DP and Howell SB (1993) Cellular accumulation of the anticancer agent cisplatin: a review. Br J Cancer 67:1171-1176.
10. Guo Y, Smith K, Lee J, Thiele DJ, and Petris MJ (2004) Identification of methionine-rich clusters that regulate copper-stimulated endocytosis of the human Ctr1 copper transporter. J Biol Chem 279:17428-17433.
11. Hamilton TC, Winker MA, Louie KG, Batist G, Rine RL, Behrens BC, Tsuruo T, Grotzinger KR, McKoy WM, Young RC, et al. (1985) Augmentation of adriamycin, melphalan and cisplatin cytotoxicity by buthionine sulfoximine depletion of glutathione in drug resistant human ovarian cancer. Proc Am Assoc Cancer Res 26:34519.
12. Holzer A, Katano K, Klomp L, and Howell S (2004) Cisplatin rapidly down-regulates its own influx transporter hCTR1 in cultured human ovarian carcinoma cells. Clin Cancer Res, in press.
13. Ishida S, Lee J, Thiele DJ, and Herskowitz I (2002) Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals. Proc Natl Acad Sci USA 99:14298-14302.
14. Katano K, Kondo A, Safaei R, Holzer A, Samimi G, Mishima M, Kuo Y-M, Rochdi M, and Howell S (2002) Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper. Cancer Res 62:6559-6565.
15. Klomp AE, Tops BB, Van Denberg IE, Berger R, and Klomp LW (2002) Biochemical characterization and subcellular localization of human copper transporter 1 (hCTR1). Biochem J 364:497-505.
16. Kuo YM, Zhou B, Cosco D, and Gitschier J (2001) The copper transporter CTR1 provides an essential function in mammalian embryonic development. Proc Natl Acad Sci USA 98:6836-6841.
17. Lee J, Pena MM, Nose Y, and Thiele DJ (2002) Biochemical characterization of the human copper transporter Ctr1. J Biol Chem 277:4380-4387.
18. Lee J, Prohaska JR, and Thiele DJ (2001) Essential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development. Proc Natl Acad Sci USA 98:6842-6847.
19. Lin X, Okuda T, Holzer A, and Howell SB (2002) The copper transporter CTR1 regulates cisplatin uptake in Saccharomyces cerevisiae. Mol Pharmacol 62:1154-1159.
20. Linder MC and Hazegh-Azam M (1996) Copper biochemistry and molecular biology. Am J Clin Nutr 63:797S-811S.
21. Mann SC, Andrews PA, and Howell SB (1991) Modulation of cis-diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3-isobutyl-1-methylxanthine in sensitive and resistant human ovarian carcinoma cells. Int J Cancer 48:866-872.
22. Moller LB, Petersen C, Lund C, and Horn N (2000) Characterization of the hCTR1 gene: genomic organization, functional expression and identification of a highly homologous processed gene. Gene 257:13-22.
23. Petris MJ, Smith K, Lee J, and Thiele DJ (2003) Copper-stimulated endocytosis and degradation of the human copper transporter, hCtr1. J Biol Chem 278:9639-9646.
24. Petris MJ, Voskoboinik I, Cater M, Smith K, Kim BE, Llanos RM, Strausak D, Camakaris J, and Mercer JF (2002) Copper-regulated trafficking of the Menkes disease copper ATPase is associated with formation of a phosphorylated catalytic intermediate. J Biol Chem 12:46736-46742.
25. Pufahl RA, Singer CP, Peariso PCL, Lin SJ, Schmidt PJ, Fahrni CJ, Culotta VC, Penner-Hahn JE, and O'Halloran TV (1997) Metal ion chaperone function of the soluble Copper(I) receptor Atxl. Science (Wash DC) 278:853-856.
26. Rae TD, Schmidt PJ, Pufahl RA, Culotta VC, and O'Halloran TV (1999) Undetectable intracellular free copper: the requirement of a copper chaperone for superoxide dismutase. Science (Wash DC) 284:805-808.
27. Zhou B and Gitschier J (1997) hCTR1: A human gene for copper uptake identified by complementation in yeast. Proc Natl Acad Sci USA 94:7481-7486.